Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells.
Bone healing poses a challenge for clinicians due to the bone’s poor regenerative property. While autologous bone grafting remains the most common solution for bone defects, it causes various proven side effects. Recent developments seem to suggest that cell-based bone tissue engineering (BTE) invol...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/15457 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-15457 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-154572023-02-28T18:03:48Z Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. Toh, Tai Chong. School of Biological Sciences A*STAR Institute of Bioengineering and Nanotechnology Lou, Yan Ru Yue, Zhilian DRNTU::Science::Biological sciences::Cytology Bone healing poses a challenge for clinicians due to the bone’s poor regenerative property. While autologous bone grafting remains the most common solution for bone defects, it causes various proven side effects. Recent developments seem to suggest that cell-based bone tissue engineering (BTE) involving human mesenchymal stem cells (hMSCs) is a more viable solution. This project aims to characterize the proliferative and osteoinductive effects of 1,25-(OH)2-D3 on hMSCs, by subjecting the cells to various concentrations of 1,25-(OH)2-D3 in vitro. Our results highlighted the dose-dependent growth inhibitory effects on hMSCs after 1,25-(OH)2-D3 administration. In addition, we have shown that supra-physiological concentrations (1 nM and 10 nM) of 1,25-(OH)2-D3 up-regulated various osteogenic markers including alkaline phosphatase (ALP) activity, extracellular mineralization, osteocalcin secretion, mRNA expression of osteocalcin and osteopontin , and also promoted early onset of hMSC morphological changes. Conversely, physiological concentrations (0.05 nM and 0.1 nM) of 1,25-(OH)2-D3 produced limited osteoinductive effects in vitro. As a practical application, 1,25-(OH)2-D3 was encapsulated in a nanoparticle, PEGylated polyaspartic acid with L-phenylalanine side chains (PAph-5), as a vehicle for in vitro delivery to hMSCs. This project has underlined the clinical implications of 1,25-(OH)2-D3 and demonstrated its potential application to BTE with the aid of nanotechnology. *I will like to express my gratitude to Institute of Bioengineering and Nanotechnology (IBN), IBN Youth Research Program, Biomedical Research Council and A*STAR, for their support that made this work possible. Bachelor of Science in Biological Sciences 2009-05-04T04:49:15Z 2009-05-04T04:49:15Z 2009 2009 Final Year Project (FYP) http://hdl.handle.net/10356/15457 en Nanyang Technological University 46 p. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
DRNTU::Science::Biological sciences::Cytology |
spellingShingle |
DRNTU::Science::Biological sciences::Cytology Toh, Tai Chong. Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. |
description |
Bone healing poses a challenge for clinicians due to the bone’s poor regenerative property. While autologous bone grafting remains the most common solution for bone defects, it causes various proven side effects. Recent developments seem to suggest that cell-based bone tissue engineering (BTE) involving human mesenchymal stem cells (hMSCs) is a more viable solution. This project aims to characterize the proliferative and osteoinductive effects of 1,25-(OH)2-D3 on hMSCs, by subjecting the cells to various concentrations of 1,25-(OH)2-D3 in vitro. Our results highlighted the dose-dependent growth inhibitory effects on hMSCs after 1,25-(OH)2-D3 administration. In addition, we have shown that supra-physiological concentrations (1 nM and 10 nM) of 1,25-(OH)2-D3 up-regulated various osteogenic markers including alkaline phosphatase (ALP) activity, extracellular mineralization, osteocalcin secretion, mRNA expression of osteocalcin and osteopontin , and also promoted early onset of hMSC morphological changes. Conversely, physiological concentrations (0.05 nM and 0.1 nM) of 1,25-(OH)2-D3 produced limited osteoinductive effects in vitro. As a practical application, 1,25-(OH)2-D3 was encapsulated in a nanoparticle, PEGylated polyaspartic acid with L-phenylalanine side chains (PAph-5), as a vehicle for in vitro delivery to hMSCs. This project has underlined the clinical implications of 1,25-(OH)2-D3 and demonstrated its potential application to BTE with the aid of nanotechnology.
*I will like to express my gratitude to Institute of Bioengineering and Nanotechnology (IBN), IBN Youth Research Program, Biomedical Research Council and A*STAR, for their support that made this work possible. |
author2 |
School of Biological Sciences |
author_facet |
School of Biological Sciences Toh, Tai Chong. |
format |
Final Year Project |
author |
Toh, Tai Chong. |
author_sort |
Toh, Tai Chong. |
title |
Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. |
title_short |
Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. |
title_full |
Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. |
title_fullStr |
Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. |
title_full_unstemmed |
Osteoinductive effects of 1α, 25 Dihydroxyvitamin D3 on human mesenchymal stem cells. |
title_sort |
osteoinductive effects of 1α, 25 dihydroxyvitamin d3 on human mesenchymal stem cells. |
publishDate |
2009 |
url |
http://hdl.handle.net/10356/15457 |
_version_ |
1759855663080538112 |